Abstract:Metabotropic glutamate receptor subtype 1 (mGluR1) is a crucial molecular target in the central nervous system disorders. 4-F-18-fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide (F-18-FITM) has been recently developed as a useful PET ligand for mGluR1 imaging in our laboratory. In this study, we aimed to measure the affinity and density of mGluR1 using PET with F-18-FITM in rat brain under the in vivo conditions. Methods: Binding potentials (BPND) and amounts of specific binding (bound ligand concentration) at equilibrium state in brain regions were noninvasively estimated using the equilibrium analysis combined with the receptor-blocked approach (EA RBA) for kinetic analysis of F-18-FITM PET results in place of reference tissue methods. Using BPND and specific binding values of rats treated with multidose ligand, we performed Scatchard analyses for in vivo measurements of mGluR1 density (maximum number of binding sites, or B-max) and ligand affinity (dissociation constant, or K-d) in brain regions, respectively. Results: The pretreatment of rats with unlabeled FITM (1 mg/kg) occupied an mGluR1 binding site of F-18-FITM by more than 99% and did not affect the input function. Hence, we used the tissue time-activity curve for receptor-blocked rats as representative of the nondisplaceable (free and nonspecific binding of radioligand) compartment. The BPND based on EA RBA showed a high correlation with the BPND based on invasive Logan plot graphical analysis in the thalamus, hippocampus, striatum, and cingulate cortex. The K-d (nM) and B-max (pmol/mL) obtained by the Scatchard analyses with the multidose ligand assays were 2.1 and 36.3, respectively, for the thalamus; 2.1 and 27.5, respectively, for the hippocampus; 1.5 and 22.2, respectively, for the striatum; and 1.5 and 20.5, respectively, for the cingulate cortex with a high confidence. Conclusion: Our study is the first to our knowledge to measure the in vivo affinity (K-d and binding potential) of F-18-FITM and mGluR1 density (B-max) with a high correlation to in vitro values in rat brain regions. This measurement using PET with F-18-FITM would be a useful index for research about mGluR1 functions in central nervous system disorders and development of new pharmaceuticals.

[3H]-L-2-amino-4-phosphonobutyrate labels a metabotropic glutamate receptor, mGluR4a

A comparison of 2-amino-4-phosphonobutyric acid (AP4) receptors and [3H]AP4 binding sites in the rat brain

Characterization of the binding of DL-[3H]-2-amino-4-phosphonobutyrate to L-glutamate-sensitive sites on rat brain synaptic membranes

Synthesis of [3H]2-amino-4-phosphonobutyric acid and characterization of its binding to rat brain membranes: a selective ligand for the chloride/calcium-dependent class of L-glutamate binding sites

Synthesis of [3H]2-Amino-4-phosphonobutyric acid and characterization of its binding to rat brain membranes: a selective ligand for the chloride/calcium-dependent class ofl-glutamate binding sites

Determination of L-AP4-bound Human Mglu8 Receptor Amino Terminal Domain Structure and the Molecular Basis for L-AP4's Group III Mglu Receptor Functional Potency and Selectivity.

Molecular Recognition of Metabotropic Glutamate Receptor Type 1 (mglur1): Synergistic Understanding with Free Energy Perturbation and Linear Response Modeling

Comparison of A4 and A2a binding sites in striatum and COS cells transfected with adenosine A2a receptors

The Channel-Lining 6′ Amino Acid in the Second Membrane-Spanning Region of Ionotropic GABA Receptors Has More Profound Effects on 4′-Ethynyl-4- N -Propylbicycloorthobenzoate Binding Than the 2′ Amino Acid

In vivo measurement of the affinity and density of metabotropic glutamate receptor subtype 1 in rat brain using 18F-FITM in small-animal PET.

Toward the Three-Dimensional Structure and Lysophosphatidic Acid Binding Characteristics of the LPA(4)/p2y(9)/GPR23 Receptor: a Homology Modeling Study.

Characterization and autoradiographic localization of [3H]α,β-methylene adenosine 5‘-triphosphate binding sites in human urinary bladder

Comparative-Studies On The Affinities Of Atp Derivatives For P-2x-Purinoceptors In Rat Urinary-Bladder

Identification and properties of N-methyl-D-aspartate receptors in rat brain synaptic plasma membranes

Development of a micromethod to study the Na+-independent L-[3H]glutamic acid binding to rat striatal membranes. I. Biochemical and pharmacological characterization

[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors

Synthesis and Pharmacological Characterization of 4-Substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates: Identification of New Potent and Selective Metabotropic Glutamate 2/3 Receptor Agonists.

Mglur7 Undergoes Rapid Internalization in Response to Activation by the Allosteric Agonist AMN082